Induction of Severe Eosinophilic Esophagitis and Multi-Organ Inflammation by Airborne Allergens is Associated with IL-4/IL-13 and CCL11 but Not IgE in Genetic Susceptible Mice

References

• Hill DA, Spergel JM. The immunologic mechanisms of eosinophilic esophagitis. Curr Allergy Asthma Rep. 2016;16(2):9. doi:10.1007/s11882-015-0592-3
   PubMed Web of Science ®Google Scholar
• Doyle AD, Masuda MY, Kita H, Wright BL. Eosinophils in eosinophilic esophagitis: the road to fibrostenosis is paved with good intentions. Front Immunol. 2020;11:603295. doi:10.3389/fimmu.2020.603295
   PubMed Web of Science ®Google Scholar
• Navarro P, Arias Á, Arias-González L, Laserna-Mendieta EJ, Ruiz-Ponce M, Lucendo AJ. Systematic review with meta-analysis: the growing incidence and prevalence of eosinophilic esophagitis in children and adults in population-based studies. Aliment Pharmacol Ther. 2019;49(9):1116–1125. doi:10.1111/apt.15231
   PubMed Web of Science ®Google Scholar
• Patel RV, Hirano I, Gonsalves N. Eosinophilic Esophagitis: etiology and Therapy. Annu Rev Med. 2021;72(1):183–197. doi:10.1146/annurev-med-052819-023848
   PubMed Web of Science ®Google Scholar
• Spergel JM, Brown-Whitehorn TF, Beausoleil JL, et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr. 2009;48(1):30–36. doi:10.1097/MPG.0b013e3181788282
   PubMed Web of Science ®Google Scholar
• Muir A, Falk GW. Eosinophilic esophagitis: a review. JAMA. 2021;326(13):1310–1318. doi:10.1001/jama.2021.14920
   PubMed Web of Science ®Google Scholar
• Yibirin M, De Oliveira D, Valera R, Plitt AE, Lutgen S. Adverse effects associated with proton pump inhibitor use. Cureus. 2021;13(1):e12759. doi:10.7759/cureus.12759
   PubMed Web of Science ®Google Scholar
• González-Cervera J, Arias Á, Redondo-González O, Cano-Mollinedo MM, Terreehorst I, Lucendo AJ. Association between atopic manifestations and eosinophilic esophagitis: a systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2017;118(5):582–590.e2. doi:10.1016/j.anai.2017.02.006
   PubMed Web of Science ®Google Scholar
• Khan S, Guo X, Liu T, et al. An update on eosinophilic esophagitis: etiological factors, coexisting diseases, and complications. Digestion. 2021;102(3):342–356. doi:10.1159/000508191
   PubMed Web of Science ®Google Scholar
• Leung AJ, Persad S, Slae M, et al. Intestinal and gastric permeability in children with eosinophilic esophagitis and reflux esophagitis. J Pediatr Gastroenterol Nutr. 2015;60(2):236–239. doi:10.1097/mpg.0000000000000590
   PubMed Web of Science ®Google Scholar
• Hill CA, Ramakrishna J, Fracchia MS, et al. Prevalence of eosinophilic esophagitis in children with refractory aerodigestive symptoms. JAMA Otolaryngol Head Neck Surg. 2013;139(9):903–906. doi:10.1001/jamaoto.2013.4171
   PubMed Web of Science ®Google Scholar
• Mishra A, Hogan SP, Brandt EB, Rothenberg ME. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest. 2001;107(1):83–90. doi:10.1172/jci10224
   PubMed Web of Science ®Google Scholar
• Fogg MI, Ruchelli E, Spergel JM. Pollen and eosinophilic esophagitis. J Allergy Clin Immunol. 2003;112(4):796–797. doi:10.1016/S0091-6749(03)01715-9
   PubMed Web of Science ®Google Scholar
• Atkins D, Furuta GT, Liacouras CA, Spergel JM. Eosinophilic esophagitis phenotypes: ready for prime time? Pediatr Allergy Immunol. 2017;28(4):312–319. doi:10.1111/pai.12715
   PubMed Web of Science ®Google Scholar
• Carr S, Chan ES, Watson W. Eosinophilic esophagitis. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):58. doi:10.1186/s13223-018-0287-0
   PubMed Web of Science ®Google Scholar
• Clayton F, Peterson K. Eosinophilic esophagitis: pathophysiology and definition. Gastrointest Endosc Clin N Am. 2018;28(1):1–14. doi:10.1016/j.giec.2017.07.011
   PubMedGoogle Scholar
• Martin LJ, He H, Collins MH, et al. Eosinophilic esophagitis (EoE) genetic susceptibility is mediated by synergistic interactions between EoE-specific and general atopic disease loci. J Allergy Clin Immunol. 2018;141(5):1690–1698. doi:10.1016/j.jaci.2017.09.046
   PubMed Web of Science ®Google Scholar
• Davis BP. Pathophysiology of eosinophilic esophagitis. Clin Rev Allergy Immunol. 2018;55(1):19–42. doi:10.1007/s12016-017-8665-9
   PubMed Web of Science ®Google Scholar
• Straumann A, Bauer M, Fischer B, Blaser K, Simon HU. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol. 2001;108(6):954–961. doi:10.1067/mai.2001.119917
   PubMed Web of Science ®Google Scholar
• Neilsen CV, Bryce PJ. Interleukin-13 directly promotes oesophagus production of CCL11 and CCL24 and the migration of eosinophils. Clin Exp Allergy. 2010;40(3):427–434. doi:10.1111/j.1365-2222.2009.03419.x
   PubMed Web of Science ®Google Scholar
• D’Alessandro A, Esposito D, Pesce M, Cuomo R, De Palma GD, Sarnelli G. Eosinophilic esophagitis: from pathophysiology to treatment. World J Gastrointest Pathophysiol. 2015;6(4):150–158. doi:10.4291/wjgp.v6.i4.150
   PubMedGoogle Scholar
• Simon D, Cianferoni A, Spergel JM, et al. Eosinophilic esophagitis is characterized by a non-IgE-mediated food hypersensitivity. Allergy. 2016;71(5):611–620. doi:10.1111/all.12846
   PubMed Web of Science ®Google Scholar
• Rocha R, Vitor AB, Trindade E, et al. Omalizumab in the treatment of eosinophilic esophagitis and food allergy. Eur J Pediatr. 2011;170(11):1471–1474. doi:10.1007/s00431-011-1540-4
   PubMed Web of Science ®Google Scholar
• Rayapudi M, Mavi P, Zhu X, et al. Indoor insect allergens are potent inducers of experimental eosinophilic esophagitis in mice. J Leukoc Biol. 2010;88(2):337–346. doi:10.1189/jlb.0110025
   PubMed Web of Science ®Google Scholar
• Hogan SP, Mishra A, Brandt EB, et al. A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nat Immunol. 2001;2(4):353–360. doi:10.1038/86365
   PubMed Web of Science ®Google Scholar
• Rayapudi M, Rajavelu P, Zhu X, et al. Invariant natural killer T-cell neutralization is a possible novel therapy for human eosinophilic esophagitis. Clin Transl Immunol. 2014;3(1):e9. doi:10.1038/cti.2013.13
   PubMedGoogle Scholar
• Rubinstein E, Cho JY, Rosenthal P, et al. Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2011;53(4):409–416. doi:10.1097/MPG.0b013e3182182ff8
   PubMed Web of Science ®Google Scholar
• Rajavelu P, Rayapudi M, Moffitt M, Mishra A. Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol. 2012;302(7):G645–54. doi:10.1152/ajpgi.00223.2011
   PubMed Web of Science ®Google Scholar
• Venturelli N, Lexmond WS, Ohsaki A, et al. Allergic skin sensitization promotes eosinophilic esophagitis through the IL-33-basophil axis in mice. J Allergy Clin Immunol. 2016;138(5):1367–1380.e5. doi:10.1016/j.jaci.2016.02.034
   PubMed Web of Science ®Google Scholar
• Wang Z, Potter CS, Sundberg JP, Hogenesch H. SHARPIN is a key regulator of immune and inflammatory responses. J Cell Mol Med. 2012;16(10):2271–2279. doi:10.1111/j.1582-4934.2012.01574.x
   PubMed Web of Science ®Google Scholar
• HogenEsch H, Gijbels MJ, Offerman E, van Hooft J, van Bekkum DW, Zurcher C. A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice. Am J Pathol. 1993;143(3):972–982.
   PubMed Web of Science ®Google Scholar
• Gijbels MJ, Zurcher C, Kraal G, et al. Pathogenesis of skin lesions in mice with chronic proliferative dermatitis (cpdm/cpdm). Am J Pathol. 1996;148(3):941–950.
   PubMed Web of Science ®Google Scholar
• HogenEsch H, Janke S, Boggess D, Sundberg JP. Absence of Peyer’s patches and abnormal lymphoid architecture in chronic proliferative dermatitis (cpdm/cpdm) mice. J Immunol. 1999;162(7):3890–3896.
   PubMed Web of Science ®Google Scholar
• Chien SJ, Silva KA, Kennedy VE, HogenEsch H, Sundberg JP. The pathogenesis of chronic eosinophilic esophagitis in SHARPIN-deficient mice. Exp Mol Pathol. 2015;99(3):460–467. doi:10.1016/j.yexmp.2015.08.012
   PubMed Web of Science ®Google Scholar
• Eden K, Rothschild DE, McDaniel DK, Heid B, Allen IC. Noncanonical NF-κB signaling and the essential kinase NIK modulate crucial features associated with eosinophilic esophagitis pathogenesis. Dis Model Mech. 2017;10(12):1517–1527. doi:10.1242/dmm.030767
   PubMed Web of Science ®Google Scholar
• Srivastava KD, Dunkin D, Liu C, et al. Effect of antiasthma simplified herbal medicine intervention on neutrophil predominant airway inflammation in a ragweed sensitized murine asthma model. Ann Allergy Asthma Immunol. 2014;112(4):339–47.e1–2. doi:10.1016/j.anai.2014.01.021
   Web of Science ®Google Scholar
• Busse PJ, Zhang TF, Srivastava K, Schofield B, Li XM. Effect of ageing on pulmonary inflammation, airway hyperresponsiveness and T and B cell responses in antigen-sensitized and -challenged mice. Clin Exp Allergy. 2007;37(9):1392–1403. doi:10.1111/j.1365-2222.2007.02775.x
   PubMed Web of Science ®Google Scholar
• Brummund W, Resnick A, Fink JN, Kurup VP. Aspergillus fumigatus-specific antibodies in allergic bronchopulmonary aspergillosis and aspergilloma: evidence for a polyclonal antibody response. J Clin Microbiol. 1987;25(1):5–9. doi:10.1128/jcm.25.1.5-9.1987
   PubMed Web of Science ®Google Scholar
• Seymour RE, Hasham MG, Cox GA, et al. Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis. Genes Immun. 2007;8(5):416–421. doi:10.1038/sj.gene.6364403
   PubMed Web of Science ®Google Scholar
• Gurung P, Sharma BR, Kanneganti TD. Distinct role of IL-1β in instigating disease in Sharpin(cpdm) mice. Sci Rep. 2016;6(1):36634. doi:10.1038/srep36634
   PubMed Web of Science ®Google Scholar
• Simon D, Marti H, Heer P, Simon HU, Braathen LR, Straumann A. Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases. J Allergy Clin Immunol. 2005;115(5):1090–1092. doi:10.1016/j.jaci.2005.01.017
   PubMed Web of Science ®Google Scholar
• Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128(1):3–20.e6;quiz 21–2. doi:10.1016/j.jaci.2011.02.040
   Web of Science ®Google Scholar
• Roy-Ghanta S, Larosa DF, Katzka DA. Atopic characteristics of adult patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2008;6(5):531–535. doi:10.1016/j.cgh.2007.12.045
   PubMed Web of Science ®Google Scholar
• Parfitt JR, Gregor JC, Suskin NG, Jawa HA, Driman DK. Eosinophilic esophagitis in adults: distinguishing features from gastroesophageal reflux disease: a study of 41 patients. Mod Pathol. 2006;19(1):90–96. doi:10.1038/modpathol.3800498
   PubMed Web of Science ®Google Scholar
• Potter JW, Saeian K, Staff D, et al. Eosinophilic esophagitis in adults: an emerging problem with unique esophageal features. Gastrointest Endosc. 2004;59(3):355–361. doi:10.1016/S0016-5107(03)02713-5
   PubMed Web of Science ®Google Scholar
• Straumann A, Aceves SS, Blanchard C, et al. Pediatric and adult eosinophilic esophagitis: similarities and differences. Allergy. 2012;67(4):477–490. doi:10.1111/j.1398-9995.2012.02787.x
   PubMed Web of Science ®Google Scholar
• Loizou D, Enav B, Komlodi-Pasztor E, et al. A pilot study of omalizumab in eosinophilic esophagitis. PLoS One. 2015;10(3):e0113483. doi:10.1371/journal.pone.0113483
   PubMed Web of Science ®Google Scholar
• Camilleri AE, Nag S, Russo AR, Stiles KM, Crystal RG, Pagovich OE. Gene therapy for a murine model of eosinophilic esophagitis. Allergy. 2021;76(9):2740–2752. doi:10.1111/all.14822
   PubMed Web of Science ®Google Scholar
• Guarino MP, Cicala M, Behar J. Eosinophilic esophagitis: new insights in pathogenesis and therapy. World J Gastrointest Pharmacol Ther. 2016;7(1):66–77. doi:10.4292/wjgpt.v7.i1.66
   PubMedGoogle Scholar
• Pietrzak B, Tomela K, Olejnik-Schmidt A, Mackiewicz A, Schmidt M. Secretory IgA in intestinal mucosal secretions as an adaptive barrier against microbial cells. Int J Mol Sci. 2020;21(23):9254. doi:10.3390/ijms21239254
   PubMed Web of Science ®Google Scholar
• Weidlich S, Nennstiel S, Jesinghaus M, et al. IgG4 is elevated in eosinophilic esophagitis but not in gastroesophageal reflux disease patients. J Clin Gastroenterol. 2020;54(1):43–49. doi:10.1097/mcg.0000000000001154
   PubMed Web of Science ®Google Scholar
• Niranjan R, Rayapudi M, Mishra A, Dutt P, Dynda S, Mishra A. Pathogenesis of allergen-induced eosinophilic esophagitis is independent of interleukin (IL)-13. Immunol Cell Biol. 2013;91(6):408–415. doi:10.1038/icb.2013.21
   PubMed Web of Science ®Google Scholar
• Wong SW, Ting YW, Yong YK, et al. Chronic inflammation involves CCL11 and IL-13 to facilitate the development of liver cirrhosis and fibrosis in chronic hepatitis B virus infection. Scand J Clin Lab Invest. 2021;81(2):147–159. doi:10.1080/00365513.2021.1876245
   PubMed Web of Science ®Google Scholar
• Zhou X, Hu H, Balzar S, Trudeau JB, Wenzel SE. MAPK regulation of IL-4/IL-13 receptors contributes to the synergistic increase in CCL11/eotaxin-1 in response to TGF-β1 and IL-13 in human airway fibroblasts. J Immunol. 2012;188(12):6046–6054. doi:10.4049/jimmunol.1102760
   PubMed Web of Science ®Google Scholar
• Young E, Philpott H. Pathophysiology of dysphagia in eosinophilic esophagitis: causes, consequences, and management. Dig Dis Sci. 2022;67(4):1101–1115. doi:10.1007/s10620-022-07419-6
   PubMed Web of Science ®Google Scholar
• Aceves SS. Remodeling and fibrosis in chronic eosinophil inflammation. Dig Dis. 2014;32(1–2):15–21. doi:10.1159/000357004
   PubMed Web of Science ®Google Scholar